Help guide internal conversations and begin to assess evidence gaps for your therapeutic with UBC’s Evidence Generation Checklist.
Learn how UBC seamlessly assembled a PV program that included the migration of more than 11,000 existing cases.
As the cell and gene therapy pipeline evolves, manufacturers are now faced with the need to provide long-term safety and efficacy data.
Patient support requires a careful balance between personal connection and technological efficiencies.
Figure out how to maximize product value with early, integrated RWE planning.
Discover what technology requirements will enable seamless ingestion and analysis of disparate sources of real-world data.
RWD and RWE are emerging as strategic tools in rare disease study design to address research challenges with real-world solutions.
Keep up to date with strategic planning best practices and patient-centric, modern study design.
Real-World-Evidence, Health Economics and Outcome Research, and Epidemiology: An Integrated Approach
Recent breakthroughs in the use of multidisciplinary evidence generation are accelerating drug development and reshaping market access.
Recent regulatory & payer decisions generated excitement in Alzheimer’s disease research, but necessitate understanding & planning for post-marketing research.